Citable company snapshot

BSX company facts in plain English

Server-rendered

Boston Scientific's latest SEC-sourced 2026-03-31 period shows $5.20B in revenue and $1.34B in net income.

BSX company facts in plain English
MetricLatest periodLatest valuePrior valueYoY
xbrl:RevenueFromContractWithCustomerExcludingAssessedTaxMar 31, 2026$5.20B$5.29B-1.6%
xbrl:GrossProfitMar 31, 2026$3.61B$3.68B-1.7%
xbrl:OperatingIncomeLossMar 31, 2026$1.10B$825.00M+33.5%
xbrl:NetIncomeLossAvailableToCommonStockholdersBasicMar 31, 2026$1.34B$672.00M+99.6%
xbrl:NetCashProvidedByUsedInOperatingActivitiesMar 31, 2026$348.00M$1.36B-74.5%
Free Cash Flow (computed)Mar 31, 2026$171.00M$1.01B-83.1%

Source: SEC EDGAR XBRL; period Mar 31, 2026; filed May 1, 2026; accession 0000885725-26-000033.

Continue research

Follow same-sector companies and source explainers connected to the overview view.

Browse Health Care